In Tel Aviv Sourasky Medical Center will be build the first national center for proton radiation cancer therapy.
Proton therapy is a type of radiation therapy that uses protons, positively charged particles, to treat cancer. The therapy has a lower risk of damage the adjacent healthy tissues of the tumor and of side effects such as low blood count and nausea.
It also enables the delivery dose directly to tumors, increasing the chances that all tumor cells will be destroyed. Not all types of cancers can be treated with proton therapy, it can be used mainly with nonmetastatic tumors with clear, defined borders.
The construction of the center is estimated to cost between $50 million and $100 million, but the project will be funded completely from donations already raised.
Galbiati Group is an Italian company, internationally-recognized for the quality of its machining, mechanical engineering and construction. Is active also in the medical sector with its high standard in quality.